ERBB3 and carcinoma: As shown in this figure, EGFR and ErbB-3 are primarily expressed in human carcinomas (50% ∼ 70%); ErbB-2 is expressed in 20% ∼ 30% of these carcinomas; and the expression of ErbB-4 occurs only in breast and colon carcinomas.